Literature DB >> 2350761

Relationships between heparanase activity and increasing metastatic potential of fibroblasts transfected with various oncogenes.

L C Schwarz1, T Inoue, T Irimura, J E Damen, A H Greenberg, J A Wright.   

Abstract

We have examined the effects of transformation by activated H-ras and other transforming oncogenes on the activity of the enzyme, heparanase. Degradation of 3H-N-acetylated-partially N-desulfated heparan sulfate by cellular extracts of the transformants was assessed by gel permation chromatography. More extensive degradation was observed with 10T1/2 mouse embryo fibroblasts transfected with an activated H-ras oncogene. The cells having the highest metastatic potential (CIRAS-3) were shown to contain the greatest heparanase activity, giving 49% higher levels of activity than parental cells (P less than 0.0002). Furthermore, the enzyme activity produced by a series of H-ras transformed cell lines increased progressively with metastatic potential (non-parametric rank correlation coefficient r = 0.96). Transfection of NIH 3T3 fibroblasts with activated H-ras, v-src or v-fes oncogenes, which induced the metastatic phenotype, did not lead to large increases in heparanase activities. Also, inhibition of ras-induced malignancy by cotransfection of rat REF cells with the Ad2 E1a oncogene did not produce significant declines in heparanase activities. These results are consistent with the view that modifications in heparanase activity can play a role in the complex process of metastasis in some, but not all situations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2350761     DOI: 10.1016/0304-3835(90)90101-3

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  5 in total

1.  Human heparanase-1 gene expression in pancreatic adenocarcinoma.

Authors:  Anthony W Kim; Xiulong Xu; Edward F Hollinger; Paolo Gattuso; Constantine V Godellas; Richard A Prinz
Journal:  J Gastrointest Surg       Date:  2002 Mar-Apr       Impact factor: 3.452

Review 2.  Heparanase and hepatocellular carcinoma: promoter or inhibitor?

Authors:  Shuo Dong; Xiong-Zhi Wu
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

3.  The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.

Authors:  J Kleeff; T Ishiwata; A Kumbasar; H Friess; M W Büchler; A D Lander; M Korc
Journal:  J Clin Invest       Date:  1998-11-01       Impact factor: 14.808

4.  Chemotactic response to mucin by Serpulina hyodysenteriae and other porcine spirochetes: potential role in intestinal colonization.

Authors:  J A Milner; R Sellwood
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

5.  Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma.

Authors:  J Rohloff; J Zinke; K Schoppmeyer; A Tannapfel; H Witzigmann; J Mössner; C Wittekind; K Caca
Journal:  Br J Cancer       Date:  2002-04-22       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.